Elke Verhey

1.3k total citations
20 papers, 938 citations indexed

About

Elke Verhey is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Elke Verhey has authored 20 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Elke Verhey's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (14 papers) and Hepatitis B Virus Studies (13 papers). Elke Verhey is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (14 papers) and Hepatitis B Virus Studies (13 papers). Elke Verhey collaborates with scholars based in Netherlands, Türkiye and Poland. Elke Verhey's co-authors include Bettina E. Hansen, Harry L.A. Janssen, Krzysztof Simon, Meral Akdoğan, Fehmı Tabak, Yılmaz Çakaloğlu, Anneke J. van Vuuren, Vincent Rijckborst, Martijn J. ter Borg and Péter Ferenci and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Elke Verhey

20 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elke Verhey Netherlands	13	702	568	188	143	90	20	938
Zsuzsanna Vitális Hungary	13	352 0.5×	289 0.5×	109 0.6×	135 0.9×	61 0.7×	34	544
Marcus M. Mücke Germany	15	453 0.6×	454 0.8×	92 0.5×	32 0.2×	76 0.8×	39	710
Sidsel Støy Denmark	13	343 0.5×	225 0.4×	83 0.4×	72 0.5×	96 1.1×	26	583
Shin Fujioka Japan	11	206 0.3×	140 0.2×	72 0.4×	98 0.7×	153 1.7×	36	479
Lydia L. Barlow United States	8	311 0.4×	284 0.5×	41 0.2×	26 0.2×	78 0.9×	10	486
Kathryn Nash United Kingdom	12	185 0.3×	134 0.2×	64 0.3×	56 0.4×	86 1.0×	25	429
Vishal Garg India	11	651 0.9×	659 1.2×	241 1.3×	16 0.1×	57 0.6×	29	890
Andy Yu United States	11	296 0.4×	234 0.4×	181 1.0×	14 0.1×	50 0.6×	22	551
K Kiyosawa Japan	12	523 0.7×	528 0.9×	83 0.4×	16 0.1×	32 0.4×	38	787
Piergiorgio Mosca Italy	10	168 0.2×	206 0.4×	119 0.6×	58 0.4×	38 0.4×	16	372

Countries citing papers authored by Elke Verhey

Since Specialization

Citations

This map shows the geographic impact of Elke Verhey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Verhey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Verhey more than expected).

Fields of papers citing papers by Elke Verhey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Verhey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Verhey. The network helps show where Elke Verhey may publish in the future.

Co-authorship network of co-authors of Elke Verhey

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Verhey. A scholar is included among the top collaborators of Elke Verhey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Verhey. Elke Verhey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farag, Mina, Margo J. H. van Campenhout, Milan J. Sonneveld, et al.. (2024). Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B. Journal of Viral Hepatitis. 31(4). 197–207. 7 indexed citations

Campenhout, Margo J. H. van, Willem Pieter Brouwer, Qing Xie, et al.. (2018). Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Journal of Viral Hepatitis. 26(1). 109–117. 14 indexed citations

Chi, Heng, Bettina E. Hansen, Simin Guo, et al.. (2017). Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON). The Journal of Infectious Diseases. 215(7). 1085–1093. 36 indexed citations

Martens, Jasper M., Bettina E. Hansen, Bob Knippenberg, et al.. (2016). Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial. Circulation Cardiovascular Interventions. 9(2). e002376–e002376. 64 indexed citations

Brouwer, Willem Pieter, Qing Xie, Milan J. Sonneveld, et al.. (2014). Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study). Hepatology. 61(5). 1512–1522. 120 indexed citations

Brouwer, Willem Pieter, Qing Xie, Milan J. Sonneveld, et al.. (2014). O3 ADDING PEGINTERFERON TO ENTECAVIR INCREASES RESPONSE RATES IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: WEEK 96 RESULTS OF A GLOBAL MULTICENTER RANDOMISED TRIAL (ARES STUDY). Journal of Hepatology. 60(1). S2–S2. 7 indexed citations

Dewint, Pieter, Bettina E. Hansen, Elke Verhey, et al.. (2013). Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut. 63(2). 292–299. 165 indexed citations

Rijckborst, Vincent, Péter Ferenci, Meral Akdoğan, et al.. (2012). Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a. European Journal of Gastroenterology & Hepatology. 24(9). 1012–1019. 7 indexed citations

Dewint, Pieter, Bettina E. Hansen, Elke Verhey, et al.. (2012). OP16 Adding ciprofloxacin to adalimumab results in a higher fistula closure rate in perianal fistulizing Crohn's disease. Journal of Crohn s and Colitis. 6. S8–S8. 1 indexed citations

10.

Dewint, Pieter, Bettina E. Hansen, Elke Verhey, et al.. (2012). 1160 Adding Ciprofloxacin to Adalimumab Results in a Higher Fistula Closure Rate in Perianal Fistulizing Crohn's Disease. Gastroenterology. 142(5). S–212. 3 indexed citations

11.

Rijckborst, Vincent, Martijn J. ter Borg, Yılmaz Çakaloğlu, et al.. (2010). A Randomized Trial of Peginterferon α-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B. The American Journal of Gastroenterology. 105(8). 1762–1769. 74 indexed citations

12.

Rijckborst, Vincent, Bettina E. Hansen, Yılmaz Çakaloğlu, et al.. (2010). Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels†. Hepatology. 52(2). 454–461. 186 indexed citations

13.

Rijckborst, Vincent, Bettina E. Hansen, Yılmaz Çakaloğlu, et al.. (2010). 8 EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS. Journal of Hepatology. 52. S4–S5. 6 indexed citations

14.

Buster, Erik H.C.J., Hajo J. Flink, Halis Şimşek, et al.. (2009). Early HBeAg Loss During Peginterferon α-2b Therapy Predicts HBsAg Loss: Results of a Long-Term Follow-Up Study in Chronic Hepatitis B Patients. The American Journal of Gastroenterology. 104(10). 2449–2457. 22 indexed citations

15.

Bergmann, Jean‐François, Jan Maarten Vrolijk, Peter van der Schaar, et al.. (2007). γ‐Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon‐α‐2b in chronic hepatitis C non‐responders. Liver International. 27(9). 1217–1225. 27 indexed citations

16.

Verhey, Elke, Robert E. Poelmann, Ko Willems van Dijk, et al.. (2007). Metabolomics (liver and blood profiling) in a mouse model in response to fasting: A study of hepatic steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(10). 1263–1270. 80 indexed citations

17.

Flink, Hajo J., Bettina E. Hansen, E. Jenny Heathcote, et al.. (2006). Successful Treatment with Peginterferon alfa-2b of HBeAg-positive HBV Non-Responders to Standard Interferon or Lamivudine. The American Journal of Gastroenterology. 101(11). 2523–2529. 21 indexed citations

18.

Veldt, Bart J., Bettina E. Hansen, Kenji Ikeda, et al.. (2006). Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon. Scandinavian Journal of Gastroenterology. 41(9). 1087–1094. 34 indexed citations

19.

Zonneveld, Monika van, Hajo J. Flink, Elke Verhey, et al.. (2005). The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation. Alimentary Pharmacology & Therapeutics. 21(9). 1163–1171. 57 indexed citations

20.

Heijden, Robert van der, et al.. (1989). Characterization of a Suspension Culture ofTabernaemontana eleganson Growth, Nutrient Uptake, and Accumulation of Indole Alkaloids*. Planta Medica. 55(2). 158–162. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact